The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient RegisterDivision of Surgery, Department of Clinical and Experimental Medicine, Faulty of Health Sciences, Linköping University; Department of Surgery, County Council of Östergötland Linköping, Linköping, Sweden.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Surgery, County Council of Östergötland, Linköping, Sweden.
Department of Gastroenterology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Department of Surgery, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden.
Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden.
Stockholm Gastro Center, Karolinska Institutet, Stockholm, Sweden.
Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Colorectal Cancer, Karolinska University Hospital, Stockholm, Sweden.
Unit of Internal Medicine, Institute Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Center for Clinical Research, Västmanland Hospital, Västerås, Sweden and Uppsala University, Uppsala, Sweden; Department of Pediatrics, Västmanland Hospital, Västerås, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Medicine, Region Jönköping County Council, Jönköping, Sweden; Jönköping Academy for Improvement of Health and Welfare, Jönköping University, Jönköping, Sweden.
Department of Gastroenterology, Skåne University Hospital, Malmö, Sweden.
Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, SSORG - Scandinavian Surgical Outcomes Research Group, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Department of Gastroenterology, Skåne University Hospital, Malmö, Sweden.
Department of Internal Medicine, Central Hospital, Karlstad, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Show others and affiliations
2020 (English)In: Scandinavian Journal of Gastroenterology, ISSN 0036-5521, E-ISSN 1502-7708, Vol. 55, no 4, p. 430-435Article in journal (Refereed) Published
Abstract [en]
Introduction: Whether data on International Classification of Diseases (ICD)-codes from the Swedish National Patient Register (NPR) correctly correspond to subtypes of inflammatory bowel disease (IBD) and phenotypes of the Montreal classification scheme among patients with prevalent disease is unknown.
Materials and methods: We obtained information on IBD subtypes and phenotypes from the medical records of 1403 patients with known IBD who underwent biological treatment at ten Swedish hospitals and retrieved information on their IBD-associated diagnostic codes from the NPR. We used previously described algorithms to define IBD subtypes and phenotypes. Finally, we compared these register-generated subtypes and phenotypes with the corresponding information from the medical records and calculated positive predictive values (PPV) with 95% confidence intervals.
Results: Among patients with clinically confirmed disease and diagnostic listings of IBD in the NPR (N = 1401), the PPV was 97 (96-99)% for Crohn's disease, 98 (97-100)% for ulcerative colitis, and 8 (4-11)% for IBD-unclassified. The overall accuracy for age at diagnosis was 95% (when defined as A1, A2, or A3). Examining the validity of codes representing disease phenotype, the PPV was 36 (32-40)% for colonic Crohn's disease (L2), 61 (56-65)% for non-stricturing/non-penetrating Crohn's disease behaviour (B1) and 83 (78-87)% for perianal disease. Correspondingly, the PPV was 80 (71-89)% for proctitis (E1)/left-sided colitis (E2) in ulcerative colitis.
Conclusions: Among people with known IBD, the NPR is a reliable source of data to classify most subtypes of prevalent IBD, even though misclassification commonly occurred in Crohn's disease location and behaviour and also among IBD-unclassified patients.
Place, publisher, year, edition, pages
Taylor & Francis, 2020. Vol. 55, no 4, p. 430-435
Keywords [en]
Crohn’s disease, ICD-codes, Inflammatory bowel disease, Montreal classification, National Patient Register, Swedish Quality Register for IBD, epidemiology, ulcerative colitis, validation
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-81780DOI: 10.1080/00365521.2020.1740778ISI: 000532826000007PubMedID: 32370571Scopus ID: 2-s2.0-85084438205OAI: oai:DiVA.org:oru-81780DiVA, id: diva2:1429399
2020-05-112020-05-112023-12-08Bibliographically approved